SIC
ALT icon

SJS Investment Consulting’s Altimmune ALT Stock Holding History

SJS Investment Consulting’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712 Buy
234
+218
+1,363% +$651 ﹤0.01% 2138
2026
Q1 		$50 Buy
+16
New +$68 ﹤0.01% 2251

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
BWM
Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SJS Investment Consulting's ALT Position: Q2 2026 in Review

SJS Investment Consulting increased its Altimmune (ALT) stake by 1,363% in Q2 2026, buying an estimated $651 and bringing the position to 234 shares worth $712. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

SJS Investment Consulting first reported a position in ALT in Q1 2026 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • SJS Investment Consulting held 234 shares of Altimmune worth $712 as of Q2 2026.
  • SJS Investment Consulting bought 218 Altimmune shares in Q2 2026, an estimated $651.
  • Altimmune made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2138 holding.
  • SJS Investment Consulting first reported a position in Altimmune in Q1 2026 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.